MedPath

Cefuroxime axetil

Cefuroxime axetil

Approved
Approval ID

1f35ed70-4947-4d4d-b4c8-71ce520fc445

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 22, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefuroxime axetil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-150
Application NumberANDA065308
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime axetil
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 17, 2008
FDA Product Classification

INGREDIENTS (5)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
Cefuroxime AxetilActive
Quantity: 500 mg in 1 1
Code: Z49QDT0J8Z
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT

Cefuroxime axetil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-370
Application NumberANDA065308
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime axetil
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 17, 2008
FDA Product Classification

INGREDIENTS (5)

Cefuroxime AxetilActive
Quantity: 250 mg in 1 1
Code: Z49QDT0J8Z
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefuroxime axetil - FDA Drug Approval Details